INKT · MiNK Therapeutics, Inc.
$11.27
+0.27 (+2.45%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the completion of anticipated funding is not entirely within the Company's control, the Company is required to disclose that substantial doubt exists about its ability to continue as a going concern for a period of one year after the date of filing of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 13, 2026
Market Cap
$57.51M
Shares
5.10M
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
Short Squeeze Score
59/100
Short interest 1.8% of shares — P49
Days to cover 9.4 — P88
Price vs VWAP -2.8% — P35
Short-volume trend -11.7% — P15
Short interest change -5.5% — P37
Worst FTD 0.02% of shares — P53
Earnings soon +10
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
| 2026-07-31 | 94,092 | 99,574 | -5,482 | 9.37 |
| 2026-07-15 | 99,574 | 112,459 | -12,885 | 6.81 |
| 2026-06-30 | 112,459 | 115,835 | -3,376 | 6.05 |
| 2026-06-15 | 115,835 | 116,445 | -610 | 2.73 |
| 2026-05-29 | 116,445 | 122,957 | -6,512 | 2.19 |
| 2026-05-15 | 122,957 | 97,106 | +25,851 | 4.44 |
| 2026-04-30 | 97,106 | 96,493 | +613 | 1.72 |
| 2026-04-15 | 96,493 | 139,115 | -42,622 | 1.88 |
| 2026-03-31 | 139,115 | 149,702 | -10,587 | 1.78 |
| 2026-03-13 | 149,702 | 37,106 | +112,596 | 1.00 |
| 2026-02-27 | 37,106 | 31,417 | +5,689 | 8.60 |
| 2026-02-13 | 31,417 | 33,451 | -2,034 | 3.85 |
| 2026-01-30 | 33,451 | 31,835 | +1,616 | 2.80 |
| 2026-01-15 | 31,835 | 32,992 | -1,157 | 3.28 |
| 2025-12-31 | 32,992 | 35,890 | -2,898 | 1.63 |
| 2025-12-15 | 35,890 | 39,293 | -3,403 | 1.75 |
| 2025-11-28 | 39,293 | 34,041 | +5,252 | 1.98 |
| 2025-11-14 | 34,041 | 38,992 | -4,951 | 1.63 |
| 2025-10-31 | 38,992 | 54,374 | -15,382 | 1.92 |
| 2025-10-15 | 54,374 | 69,270 | -14,896 | 1.53 |
| 2025-09-30 | 69,270 | 49,049 | +20,221 | 1.55 |
| 2025-09-15 | 49,049 | 48,601 | +448 | 1.02 |
| 2025-08-29 | 48,601 | 72,379 | -23,778 | 1.01 |
Showing 1–23 of 23 settlements
Key facts
CIK
1840229
CUSIP
603693201
13F (30d)
28 filings
28 filers
Visit website
Investor relations